Skip to main content
AAPS PharmSci logoLink to AAPS PharmSci
. 2000 Aug 16;2(3):45–52. doi: 10.1208/ps020324

Direct pelletization in a rotary processor controlled by torque measurements. II: Effects of changes in the content of microcrystalline cellulose

Jakob Kristensen 1,, Torben Schæfer 1, Peter Kleinebudde 2
PMCID: PMC2761135  PMID: 11741240

Abstract

In the present study we investigated the effect of changes in the content of microcrystalline cellulose (MCC) on a direct pelletization process in a rotary processor in which the liquid addition was terminated once a certain increase in torque was produced. Nine different mixtures of MCC and lactose with MCC contents varying from 10% to 100% (w/w) were pelletized using 6 different torque increase levels, and the changes in pellet characteristics were investigated. The pellet characteristics investigated were pellet shape, size, and size distribution as well as the water content of the pellets at the end of liquid addition. To produce spherical agglomerates with suitable characteristics in a reproducible way, a content of a least 20% (w/w) MCC was found necessary. Linear correlations were found between the MCC content and the water content and between the torque incraase and the water content, showing that the torque increase is suitable to control the process. A higher torque increase or a higher MCC content was found to increase the water content independently of each other.

References

  • 1.Vecchio C, Bruni G, Gazzaniga A. Preparation of indobufen pellets by using centrifugal rotary fluidized bed equipment without starting seeds. Drug Dev Ind Pharm. 1994;20:1943–1956. doi: 10.3109/03639049409049329. [DOI] [Google Scholar]
  • 2.Fielden KE, Newton JM. Extrusion and extruders. In: Swarbrick J, Boylan JC, editors. Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker; 1992. pp. 395–442. [Google Scholar]
  • 3.Vertommen J, Kinget R. Influence of five selected processing and formulation variables on the particle size, particle size distribution, and friability of pellets produced in a rotary processor. Drug Dev Ind Pharm. 1997;23:39–46. doi: 10.3109/03639049709148480. [DOI] [Google Scholar]
  • 4.Holm P, Bonde M, Wigmore T. Pelletization by granulation in a roto-processor RP-2. Part 1. Effects of process and product variables on granule growth. Pharm Technol Eur. 1996;8:22–36. [Google Scholar]
  • 5.Kristensen J, Schaefer T, Kleinebudde P. Direct pelletization in a rotary processor controlled by torque measurements. I: Influence of process variables. Pharm Dev Technol. 2000;5:247–256. doi: 10.1081/PDT-100100539. [DOI] [PubMed] [Google Scholar]
  • 6.Robinson RL, Hollenbeck RG. Manufacture of spherical acetaminophen pellets: comparison of rotary processing with multiple-step extrusion and spheronization. Pharm Technol. 1991;15:48–56. [Google Scholar]
  • 7.Sienkiewicz G, Pereira R, Rudnic EM, Lausier JM, Rhodes CT. Spheronization of theophylline-avicel combinations using a fluidized-bed rotogranulation technique. Drug Dev Ind Pharm. 1997;23:173–182. doi: 10.3109/03639049709149791. [DOI] [Google Scholar]
  • 8.Holm P. Pelletization by granulation in a roto-processor RP-2. Part 2. Effects of process and product variables on agglomerates shape and porosity. Pharm Technol Eur. 1996;8:38–45. [Google Scholar]
  • 9.Vertommen J, Rombaut P, Kinget R. Shape and surface smoothness of pellets made in a rotary processor. Int J Pharm. 1997;146:21–29. doi: 10.1016/S0378-5173(96)04754-0. [DOI] [Google Scholar]
  • 10.Heng PW, Wan LS, Tan YT. Optimization of spheroid production by centrifugal rotary processing. Int J Pharm. 1996;143:107–112. doi: 10.1016/S0378-5173(96)04683-2. [DOI] [Google Scholar]
  • 11.Vertommen J, Jaucot B, Rombaut P, Kinget R. Improvement of the material motion in a rotary processor. Pharm Dev Technol. 1996;1:365–371. doi: 10.3109/10837459609031431. [DOI] [PubMed] [Google Scholar]
  • 12.Wan LS, Heng PW, Liew CV. The role of moisture and air gap pressure in the formation of spherical granules by rotary processing. Drug Dev Ind Pharm. 1994;20:2551–2561. doi: 10.3109/03639049409042659. [DOI] [Google Scholar]
  • 13.Holm P. Pelletization by granulation in a roto-processor RP-2. Part 3. Methods of proces control and the effect of microcrystalline cellulose on wet granulation. Pharm Technol Eur. 1996;8:36–46. [Google Scholar]
  • 14.Vertommen J, Rombaut P, Michoel A, Kinget R. Estination of the amount of water removed by gap and atomization air streams during pelletization in a rotary processor. Pharm Dev Technol. 1998;3:53–72. doi: 10.3109/10837459809028480. [DOI] [PubMed] [Google Scholar]
  • 15.Schaefer T, Mathiesen C. Melt pelletization in a high shear mixer. VIII. Effects of binder viscosity. Int J Pharm. 1996;139:125–138. doi: 10.1016/0378-5173(96)04549-8. [DOI] [Google Scholar]
  • 16.Wan LS, Heng PW, Liew CV. Spheronization conditions on spheroid shape and size. Int J Pharm. 1993;96:59–65. doi: 10.1016/0378-5173(93)90212-X. [DOI] [Google Scholar]
  • 17.Bains D, Boutell SL, Newton JM. The influence of moisture content on the preparation of spherical granules of barium sulphate and microcrystalline cellulose. Int J Pharm. 1991;69:233–237. doi: 10.1016/0378-5173(91)90365-U. [DOI] [Google Scholar]
  • 18.Gazzaniga A, Sangalli ME, Bruni G, Zema L, Vecchio C, Giordano F. The use of β-cyclodextrin as a pelletization agent in extrusion/spheronization process. Drug Dev Ind Pharm. 1998;24:869–873. doi: 10.3109/03639049809088533. [DOI] [PubMed] [Google Scholar]
  • 19.Kleinebudde P, Solvberg AJ, Lindner H. The powerconsumption-controlled extruder: a tool for pellet production. J Pharm Pharmacol. 1994;46:542–546. doi: 10.1111/j.2042-7158.1994.tb03853.x. [DOI] [PubMed] [Google Scholar]
  • 20.Kleinebudde P, Schroder M, Schultz P, Muller BW, Waaler T, Nymo L. Importance of the fraction of microcrystalline cellulose and spheronization speed on the properties of extruded pellets made from binary mixtures. Pharm Dev Technol. 1999;4:397–404. doi: 10.1081/PDT-100101375. [DOI] [PubMed] [Google Scholar]
  • 21.Thoma K, Ziegler I. Investigation of the influence of the type of extruder for pelletization by extrusionspheronization. II. Sphere characteristics. Drug Dev Ind Pharm. 1998;24:413–422. doi: 10.3109/03639049809085638. [DOI] [PubMed] [Google Scholar]
  • 22.Schmidt C, Kleinebudde P. Significance of the granulation step in pelletization by extrusion/spheronization. Chem Pharm Bull. 1999;47:405–412. [Google Scholar]
  • 23.Kleinebudde P. Shrinking and swelling properties of pellets containing microcrystalline cellulose (MCC) and low substituted hydroxypropylcellulose (L-HPC). Part I. Shrinking properties. Int J Pharm. 1994;109:209–219. doi: 10.1016/0378-5173(94)90383-2. [DOI] [Google Scholar]

Articles from AAPS PharmSci are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES